BBS-Bioactive Bone Substitutes
Manufacturing · Finland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Kiviharjunlenkki 6, Oulu, Northern Ostro...Phone Number
+358 207924700Website
www.bbs-artebone.fiRevenue
$6.4 MillionIndustry
About BBS-Bioactive Bone Substitutes
BBS-Bioactive Bone Substitutes Org Chart
Is BBS-Bioactive Bone Substitutes your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on BBS-Bioactive Bone Substitutes recently announced quarterly report
Product Launch: Get notified when BBS-Bioactive Bone Substitutes launches new products
Check if BBS-Bioactive Bone Substitutes has recently received funding, and reach out quickly before it becomes old news!
Click to see if BBS-Bioactive Bone Substitutes had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at BBS-Bioactive Bone Substitutes
Funding: Get notified immidiatlly once BBS-Bioactive Bone Substitutes has new funding data
BBS-Bioactive Bone Substitutes, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if BBS-Bioactive Bone Substitutes is spiking on competitors!
Recommended Actions
Find VP level buyers at BBS-Bioactive Bone Substitutes
Find 3 more new buyers
Company Profile Activity
Activity Insights
BBS-Bioactive Bone Substitutes is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BBS-Bioactive Bone Substitutes is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BBS-Bioactive Bone Substitutes.
BBS-Bioactive Bone Substitutes Tech Stack
A closer look at the technologies used by BBS-Bioactive Bone Substitutes
Most Recent Scoops
BBS-Bioactive Bone Substitutes News & Media
BBS-Bioactive Bone Substitutes Plc: 57% of warrants 2-2022 (TO2) used for the subscription of shares, company raises EUR 162,000 in gross proceeds
BBS-Bioactive Bone Substitutes Plc, Company Announcement, 7 June 2023 at 10.30 p.m. EESTBBS-Bioactive Bone Substitutes Plc: BBS arranges a rights offering of approximately maximum EUR 2.9 million
BBS-Bioactive Bone Substitutes Plc, Company Announcement, Insider information, 5 June 2023 at 09.00 a.m. EESTBBS-Bioactive Bone Substitutes Plc – Inside information – Positive decision received on the product classification, schedule for the quality system approval to be updated
BBS-Bioactive Bone Substitutes Plc, Company announcement, Insider information, 26 May 2023 at 5:30 p.m. EESTBBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
BBS-Bioactive Bone Substitutes Plc, Company announcement, 22 May 2023 4:00 p.m.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BBS-Bioactive Bone Substitutes
BBS-Bioactive Bone Substitutes Ltd. specializes in the development and production of ARTEBONE, a bone healing paste designed as a safer and more effective bone graft substitute. The company aims to cater to the growing market for bone grafts, with nearly 3 million operations performed annually worldwide. They are preparing for industrial production... Read More